China National Accord Medicines Corp Ltd (200028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (200028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting HK$95.44 Million (capex HK$50.09 Million plus investments HK$45.35 Million) from operating cash flow of HK$1.83 Billion. See cash generation quality of China National Accord Medicines Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of China National Accord Medicines Corp Ltd.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. See China National Accord Medicines Corp Ltd (200028) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (HKD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | HK$337.47 Million | HK$1.64 Billion | HK$217.35 Million | ▲ +41.3% |
| 2024 | 0.15x | HK$476.87 Million | HK$3.27 Billion | HK$282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | HK$457.64 Million | HK$2.94 Billion | HK$322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | HK$665.01 Million | HK$2.56 Billion | HK$322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | HK$514.46 Million | HK$1.66 Billion | HK$370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | HK$324.92 Million | HK$1.50 Billion | HK$293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | HK$301.17 Million | HK$2.00 Billion | HK$245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | HK$380.06 Million | HK$1.32 Billion | HK$255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | HK$217.09 Million | HK$1.29 Billion | HK$204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | HK$275.02 Million | HK$1.47 Billion | HK$265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | HK$226.73 Million | HK$1.05 Billion | HK$190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | HK$150.50 Million | HK$465.03 Million | HK$150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | HK$193.57 Million | HK$323.96 Million | HK$193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | HK$198.97 Million | HK$227.32 Million | HK$198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | HK$177.99 Million | HK$428.16 Million | HK$177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | HK$102.94 Million | HK$270.85 Million | HK$102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | HK$84.98 Million | HK$246.58 Million | HK$84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | HK$71.41 Million | HK$87.70 Million | HK$71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | HK$118.22 Million | HK$181.73 Million | HK$118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | HK$50.62 Million | HK$148.28 Million | HK$50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | HK$14.18 Million | HK$130.30 Million | HK$14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | HK$49.36 Million | HK$81.22 Million | HK$49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | HK$26.90 Million | HK$28.76 Million | HK$26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | HK$35.91 Million | HK$71.16 Million | HK$35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | HK$21.01 Million | HK$8.52 Million | HK$21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | HK$27.54 Million | HK$22.84 Million | HK$27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | HK$10.38 Million | HK$5.21 Million | HK$10.38 Million | — |